BRISTOL MYERS SQUIBB CO (BMY)
@BMY.asset
$50.57
At close:
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.
Figures
- Sector Healthcare
- Industry Drug Manufacturers
- Index S&P 500
- Market Cap $102.91 B
- Last Earnings Report Apr 24, 2025
- Price Reaction to Earnings Report -7.02%
- Enterprise Value $140.56 B
- Dividend Yield 0.05%
- P/E ratio 18.94
- Price/Sales ratio 2.15
- EV/Sales ratio 2.95
- Price/Book Value 5.88
- Revenue $47.64 B
- EBIT $0.00 B
- Net Income $5.42 B
- Gross Profit $33.57 B
- Free Cash Flow $12.91 B
- EBIT Margin ?%
- Gross Margin 70.47%
- FCF Margin 27.11%
- Return on Equity 31.05%
- Equity Ratio 18.88%
- Debt/Equity Ratio 4.30
- 6-month Performance -4.84%
- 12-month Performance 21.42%
- Trend reversal neutral
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |